美国超剂量死亡率在2025年8月结束的12个月中下降了21%至73 000人,这是几十年来最大的下降。 U.S. overdose deaths dropped 21% to 73,000 in 12 months ending Aug 2025, the largest decline in decades.

在2025年8月结束的12个月中,美国超剂量死亡率估计下降到73 000人,比上一年下降21%,这是2024年下降27%之后几十年中持续下降最久的十年。 U.S. overdose deaths declined to an estimated 73,000 in the 12 months ending August 2025, a 21% drop from the previous year, marking the longest sustained decrease in decades, following a 27% decline in 2024. 尽管亚利桑那州、夏威夷州、堪萨斯州、新墨西哥州和北达科他州的数据不完整或有所上升,但大多数州的死亡率都有所下降。 Deaths fell in most states, though data from Arizona, Hawaii, Kansas, New Mexico, and North Dakota were incomplete or showed increases. 可能的促成因素包括扩大获得内乐酮的机会,增加吸毒成瘾治疗,改变吸毒模式,解决类阿片诉讼,以及由于中国的管制行动,芬太尼供应量减少。 Possible contributing factors include expanded access to naloxone, increased addiction treatment, changes in drug use patterns, opioid lawsuit settlements, and reduced fentanyl supply due to regulatory actions in China. 一些研究人员还提出,大流行病刺激付款的结束可能发挥了作用。 Some researchers also suggest the end of pandemic stimulus payments may have played a role. 专家们告诫说,这种下降可能是由于多重重叠因素造成的,而且这一趋势已经放缓,过剂量率仍然远远高于流行前水平。 Experts caution that the decline is likely due to multiple overlapping factors, and the trend has slowed, with overdose rates still far above pre-pandemic levels.